Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
AstraZeneca
National Institutes of Health Clinical Center (CC)
PMV Pharmaceuticals, Inc
BeOne Medicines
Neonc Technologies, Inc.
Tasca Therapeutics
MacroGenics
DualityBio Inc.
Janux Therapeutics
Novelty Nobility, Inc.
Marengo Therapeutics, Inc.
Shanghai Public Health Clinical Center
Stanford University
Cofactor Genomics, Inc.
Evopoint Biosciences Inc.